Menopause and Type 1 Diabetes: What Women Need to Know
A new review of research shows that women with Type 1 diabetes experience menopause differently—and may face greater symptom severity. Yet support and information remain limited.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Women with Type 1 diabetes report menopausal symptoms similar to women without diabetes, but may experience more severe symptoms
- Hormone replacement therapy (HRT) was linked to lower HbA1c levels in some studies, but this connection is rarely discussed in diabetes care
- Very little research focuses specifically on women with Type 1 diabetes going through menopause
- Many women with diabetes report feeling poorly informed about menopause and say they lack adequate support during this transition
A Research Gap That Affects Millions
Menopause is a major life transition for all women, bringing hot flashes, mood changes, sleep problems, and other symptoms. But for women managing Type 1 diabetes, it can bring extra challenges. A new scoping review published in Diabetic Medicine examined what scientists know about how diabetes affects the menopausal experience—and found that research in this area is surprisingly limited.
Researchers searched five medical databases for studies published in peer-reviewed journals and found 22 studies worthy of detailed review. What emerged is a picture of a topic that deserves far more attention: especially for women with Type 1 diabetes, where evidence is particularly scarce.
Are Menopausal Symptoms More Severe With Type 1 Diabetes?
The research suggests that women with diabetes experience menopause differently than women without diabetes. While the types of symptoms are similar—hot flashes, night sweats, mood swings, and sleep disruption—women with diabetes may face increased severity of symptoms.
This matters because severe symptoms can affect daily life, work, and emotional wellbeing. Yet many women with Type 1 diabetes don't receive specialized guidance about what to expect or how to manage menopause alongside their diabetes care.
HRT and Diabetes: An Overlooked Connection
One finding stood out: studies linked hormone replacement therapy (HRT) use to lower HbA1c levels—a key measure of blood sugar control over time. Despite this potential connection, HRT remains largely overlooked in discussions between women with diabetes and their healthcare providers.
This gap in communication may mean that women and their doctors aren't considering how HRT decisions might affect diabetes management, or vice versa. Better conversation between endocrinologists and other specialists could help women make informed choices about their health during menopause.
Women Report Feeling Unsupported
The review found that women with diabetes often feel ill-informed about menopause and lack access to evidence-based support during this transition. Many report that healthcare providers don't adequately prepare them for what's ahead or help them manage symptoms alongside their diabetes.
This is particularly true for women with Type 1 diabetes, where the research evidence is thinnest. Women deserve clear, practical information tailored to their situation—information that currently isn't always available.
What This Means Going Forward
This review highlights the need for more research focused specifically on women with Type 1 diabetes and menopause. It also points to an opportunity: better training for healthcare providers, clearer communication about how menopause and diabetes interact, and more support resources designed for this population.
If you are a woman with Type 1 diabetes approaching or going through menopause, your experience matters. Sharing your story with your healthcare team and asking questions about how menopause may affect your diabetes management can help close the gap between the research and real-world care.
Evidence label
Source: Diabetic medicine : a journal of the British Diabetic Association. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature
- Living With T1DMetformin in Pregnancy With Type 1 Diabetes: What Early Data ShowsPubMed indexed literature
- Living With T1DTime in Tight Range: What the New CGM Metric Means for People With Type 1 DiabetesPubMed indexed literature